Man charged with supplying performance drugs to Olympians

Federal prosecutors have charged a Texas man with providing performance-enhancing drugs to athletes competing in the 2020 Olympics in Tokyo, including the star Nigerian sprinter Blessing Okagbare

Via AP news wire
Wednesday 12 January 2022 17:13
Doping Charges
Doping Charges

U.S. prosecutors charged a Texas man on Wednesday with providing performance-enhancing drugs to athletes competing in the 2020 Olympics in Tokyo including the star Nigerian sprinter Blessing Okagbare.

Eric Lira, 41, of El Paso is the first person to be charged under a new U.S. anti-doping law governing international sports competitions.

The U.S. Attorney's Office in Manhattan said Lira distributed the drugs, including human growth hormone, “for the purpose of corrupting” the 2020 Games. Lira also is accused of conspiring to violate drug misbranding and adulteration laws. It was not immediately clear whether he had an attorney who could comment on the charges.

The criminal complaint does not name Okagbare, but includes details suggesting she was among Lira’s clients. A text message was sent to Okagbare seeking comment.

Okagbare had been provisionally suspended for testing positive for human growth hormone in July 2021, just hours before the former world championships silver medalist was due to run in the semifinals of the women’s 100 meters at the Olympics. She tested positive for the drug in an out-of-competition test.

A criminal complaint unsealed in Manhattan federal court alleges that Lira, a kinesiologist and naturopathic doctor, brought “misbranded” versions of the drugs to the United States from Central and South America before distributing them to athletes.

Authorities searched Okagbare's cellphone as she was returning to the United States and found she had been communicating with Lira over using an encrypted app, according to the complaint.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in